{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:00:24Z","timestamp":1767841224506,"version":"3.49.0"},"reference-count":41,"publisher":"American Society for Microbiology","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A vaccine consisting of several conserved proteins with different functions directing the pathogenesis of pneumonia and sepsis would be preferred for protection against infection by<jats:named-content content-type=\"genus-species\">Streptococcus pneumoniae<\/jats:named-content>. Infants will be the major population targeted for next-generation pneumococcal vaccines. Here, we investigated the potential efficacy provided by three recombinant pneumococcal vaccine candidate proteins\u2014pneumococcal histidine triad D (PhtD), detoxified pneumolysin derivative (PlyD1), and pneumococcal choline-binding protein A (PcpA)\u2014for reducing pneumonia and sepsis in an infant mouse vaccine model. We found vaccination with PhtD and PcpA provided high IgG antibody titers after vaccination in infant mice, similar to adult mice comparators. PlyD1-specific total IgG was significantly lower in infant mice, with minimal boosting with the second and third vaccinations. Similar isotypes of IgG for PhtD and PlyD1 were generated in infant compared to adult mice. Although lower total specific IgG to all three proteins was elicited in infant than in adult mice, the infant mice were protected from bacteremic pneumonia and sepsis mortality (PlyD1) and had lower lung bacterial burdens (PcpA and PhtD) after challenge. The observed immune responses coupled with bacterial reductions elicited by each of the monovalent proteins support further testing in human infant clinical trials.<\/jats:p>","DOI":"10.1128\/cvi.00052-14","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T04:53:49Z","timestamp":1400734429000},"page":"1037-1045","source":"Crossref","is-referenced-by-count":14,"title":["Contributions to Protection from Streptococcus pneumoniae Infection Using the Monovalent Recombinant Protein Vaccine Candidates PcpA, PhtD, and PlyD1 in an Infant Murine Model during Challenge"],"prefix":"10.1128","volume":"21","author":[{"given":"David","family":"Verhoeven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Pichichero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2014,5,21]]},"reference":[{"key":"key20180919073738_B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.tim.2012.06.004","article-title":"Polyhistidine triad proteins of pathogenic streptococci","volume":"20","author":"Plumptre","year":"2012","journal-title":"Trends Microbiol."},{"key":"key20180919073738_B2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1128\/IAI.69.2.949-958.2001","article-title":"Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis","volume":"69","author":"Adamou","year":"2001","journal-title":"Infect. Immun."},{"key":"key20180919073738_B3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1096\/fj.08-119537","article-title":"Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H","volume":"23","author":"Ogunniyi","year":"2009","journal-title":"FASEB J."},{"key":"key20180919073738_B4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1574-6968.2006.00360.x","article-title":"Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library","volume":"262","author":"Beghetto","year":"2006","journal-title":"FEMS Microbiol. Lett."},{"key":"key20180919073738_B5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1128\/IAI.01103-06","article-title":"Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae","volume":"75","author":"Ogunniyi","year":"2007","journal-title":"Infect. Immun."},{"key":"key20180919073738_B6","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1128\/IAI.00811-09","article-title":"Interaction of pneumococcal histidine triad proteins with human complement","volume":"78","author":"Melin","year":"2010","journal-title":"Infect. Immun."},{"key":"key20180919073738_B7","doi-asserted-by":"publisher","first-page":"5495","DOI":"10.1016\/j.vaccine.2011.05.051","article-title":"A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae","volume":"29","author":"Denoel","year":"2011","journal-title":"Vaccine"},{"key":"key20180919073738_B8","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1016\/j.vaccine.2012.10.080","article-title":"Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults","volume":"30","author":"Seiberling","year":"2012","journal-title":"Vaccine"},{"key":"key20180919073738_B9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/INF.0b013e31821c2d8b","article-title":"Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children","volume":"30","author":"Kaur","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"key20180919073738_B10","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1128\/CVI.00050-09","article-title":"Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage","volume":"16","author":"Holmlund","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073738_B11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/j.1469-0691.2011.03629.x","article-title":"Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia","volume":"18","author":"Hagerman","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"key20180919073738_B12","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.vaccine.2012.02.023","article-title":"Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"key":"key20180919073738_B13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2174\/156652408785747924","article-title":"Pneumolysin: a double-edged sword during the host-pathogen interaction","volume":"8","author":"Marriott","year":"2008","journal-title":"Curr. Mol. Med."},{"key":"key20180919073738_B14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1086\/318833","article-title":"Protection against bacteremic pneumococcal infection by antibody to pneumolysin","volume":"183","author":"Musher","year":"2001","journal-title":"J. Infect. Dis."},{"key":"key20180919073738_B15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1086\/376571","article-title":"Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae","volume":"188","author":"Briles","year":"2003","journal-title":"J. Infect. Dis."},{"key":"key20180919073738_B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/10408410600822942","article-title":"Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies","volume":"32","author":"Tai","year":"2006","journal-title":"Crit. Rev. Microbiol."},{"key":"key20180919073738_B17","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1128\/IAI.06348-11","article-title":"Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury","volume":"80","author":"Salha","year":"2012","journal-title":"Infect. Immun."},{"key":"key20180919073738_B18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/IAI.74.1.586-593.2006","article-title":"Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines","volume":"74","author":"Kirkham","year":"2006","journal-title":"Infect. Immun."},{"key":"key20180919073738_B19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2012.11.005","article-title":"Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults","volume":"31","author":"Kamtchoua","year":"2013","journal-title":"Vaccine"},{"key":"key20180919073738_B20","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1128\/IAI.67.12.6533-6542.1999","article-title":"The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia","volume":"67","author":"Brooks-Walter","year":"1999","journal-title":"Infect. Immun."},{"key":"key20180919073738_B21","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1128\/IAI.01126-07","article-title":"Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis","volume":"76","author":"Glover","year":"2008","journal-title":"Infect. Immun."},{"key":"key20180919073738_B22","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1128\/IAI.74.2.1171-1180.2006","article-title":"Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence","volume":"74","author":"Johnston","year":"2006","journal-title":"Infect. Immun."},{"key":"key20180919073738_B23","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/j.1469-0691.2010.03389.x","article-title":"Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein A","volume":"17","author":"Posfay-Barbe","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"key20180919073738_B24","doi-asserted-by":"publisher","first-page":"7461","DOI":"10.1016\/j.vaccine.2012.10.076","article-title":"Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine","volume":"30","author":"Bologa","year":"2012","journal-title":"Vaccine"},{"key":"key20180919073738_B25","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.vaccine.2012.02.038","article-title":"Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants","volume":"30","author":"Ljutic","year":"2012","journal-title":"Vaccine"},{"key":"key20180919073738_B26","doi-asserted-by":"publisher","first-page":"799","DOI":"10.4161\/hv.19820","article-title":"Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children","volume":"8","author":"Pichichero","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"key20180919073738_B27","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"key20180919073738_B28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2165\/00003495-200565020-00005","article-title":"Advances in pneumococcal vaccines: advantages for infants and children","volume":"65","author":"Bernatoniene","year":"2005","journal-title":"Drugs"},{"key":"key20180919073738_B29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1128\/IAI.69.1.426-434.2001","article-title":"Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains","volume":"69","author":"Gingles","year":"2001","journal-title":"Infect. Immun."},{"key":"key20180919073738_B30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0882-4010(95)90125-6","article-title":"Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum","volume":"18","author":"Aaberge","year":"1995","journal-title":"Microb. Pathog."},{"key":"key20180919073738_B31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nm.2142","article-title":"Memory CD4 T-cells induce innate responses independently of pathogen","volume":"16","author":"Strutt","year":"2010","journal-title":"Nat. Med."},{"key":"key20180919073738_B32","first-page":"305","article-title":"The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae","volume":"1","author":"Briles","year":"1984","journal-title":"J. Mol. Cell Immunol."},{"key":"key20180919073738_B33","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1128\/IAI.72.9.5031-5040.2004","article-title":"PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin","volume":"72","author":"Shaper","year":"2004","journal-title":"Infect. Immun."},{"key":"key20180919073738_B34","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1086\/424596","article-title":"Tissue-specific contributions of pneumococcal virulence factors to pathogenesis","volume":"190","author":"Orihuela","year":"2004","journal-title":"J. Infect. Dis."},{"key":"key20180919073738_B35","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1128\/IAI.01727-06","article-title":"Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice","volume":"75","author":"Quin","year":"2007","journal-title":"Infect. Immun."},{"key":"key20180919073738_B36","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1128\/IAI.72.8.4534-4540.2004","article-title":"Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin","volume":"72","author":"Garcia-Suarez","year":"2004","journal-title":"Infect. Immun."},{"key":"key20180919073738_B37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/IAI.63.2.448-455.1995","article-title":"A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice","volume":"63","author":"Benton","year":"1995","journal-title":"Infect. Immun."},{"key":"key20180919073738_B38","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1128\/IAI.69.6.3569-3575.2001","article-title":"Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia","volume":"69","author":"Alcantara","year":"2001","journal-title":"Infect. Immun."},{"key":"key20180919073738_B39","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1128\/IAI.00290-09","article-title":"Streptococcus pneumoniae autolysis prevents phagocytosis and production of phagocyte-activating cytokines","volume":"77","author":"Martner","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073738_B40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1128\/IAI.41.3.1212-1216.1983","article-title":"Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin","volume":"41","author":"Paton","year":"1983","journal-title":"Infect. Immun."},{"key":"key20180919073738_B41","doi-asserted-by":"publisher","first-page":"e59925","DOI":"10.1371\/journal.pone.0059925","article-title":"Mucociliary clearance defects in a murine in vitro model of pneumococcal airway infection","volume":"8","author":"Fliegauf","year":"2013","journal-title":"PLoS One"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00052-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T19:56:18Z","timestamp":1597866978000},"score":1,"resource":{"primary":{"URL":"https:\/\/cvi.asm.org\/content\/21\/8\/1037"}},"subtitle":[],"editor":[{"given":"S. A.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,21]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,7,30]]},"published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1128\/CVI.00052-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00052-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,21]]}}}